Model-based predictions of brca1/2 mutation status in breast carcinoma patients treated at an academic medical center

Cancer

Volumn 94, Issue 2, 2002, Pages 305-313

  Shannon, Kristen M ^a   Lubratovich, Marcie L ^a   Finkelstein, Dianne M ^a   Smith, Barbara L ^a   Powell, Simon N ^a   Seiden, Michael V ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

BRCA1; BRCA2; Breast carcinoma; Genetic testing; Predictive models

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; AGED; ARTICLE; BREAST CARCINOGENESIS; BREAST CARCINOMA; CANCER RISK; CLINICAL ARTICLE; DIAGNOSTIC VALUE; FEMALE; GENE MUTATION; GENETIC COUNSELING; HUMAN; PRIORITY JOURNAL;

ACADEMIC MEDICAL CENTERS; ADULT; AGED; AGED, 80 AND OVER; ATTITUDE TO HEALTH; BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; FAMILY HEALTH; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HUMANS; MIDDLE AGED; MODELS, GENETIC; MODELS, THEORETICAL; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT;

EID: 0037080260     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.10223     Document Type: Article

References (27)

1. The genetic attributable risk of breast and ovarian cancer
2. Breast and ovarian cancer incidence in BRCA1 mutation carriers: Breast cancer linkage consortium
3. The genetics of breast and ovarian cancer
4. Risks of cancer in BRCA1 mutation carriers: Breast cancer linkage consortium
5. Pathology of familial breast cancer; differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases
6. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews
7. Contralateral breast cancer: Annual incidence and risk parameters
8. Prognosis in T2N0M0 stage I breast carcinoma: A 20-year follow up study
9. Cancer statistics, 1998
10. Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer
11. Prophylactic oophorectomy in inherited breast/ovarian cancer families
12. Ovarian ablation as treatment for young women with breast cancer
13. Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study
14. Statement of the American society of clinical oncology genetic testing for cancer susceptibility
15. Determining carrier probabilities for breast cancer susceptibility genes BRCA1 and BRCA2
16. BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer
17. BRCA1 sequence analysis in women at high risk for susceptibility mutations
18. Sequence analysis of BRCA1 and BRCA2: Correlation of mutations with family history and ovarian cancer risk
19. Frequency of BRCA1/BRCA2 mutations in a population-based sample of young breast carcinoma cases
20. Frequency of breast cancer attributable to BRCA1 in a population-based series of American women
21. BRCA1 mutations in a population-based sample of young women with breast cancer
22. Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer
23. Differential contributions of BRCA1 and BRCA2 to early-onset breast cancer
24. The founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi Jewish women
25. Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history
26. Psychological and social determinants of women's decisions to undergo genetic counseling and testing for breast cancer
27. Patient recall of family history of cancer: A comparison of BRCA1 and p53 families